AZD7594 + Placebo to match
Phase 1Completed 0 watching 0 views this week๐ค Quiet
33
Development Stage
โ
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Safety
Conditions
Safety, Pharmacokinetics, Pharmacodynamics of AZD7594
Trial Timeline
Sep 1, 2012 โ Jun 1, 2013
NCT ID
NCT01636024About AZD7594 + Placebo to match
AZD7594 + Placebo to match is a phase 1 stage product being developed by AstraZeneca for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT01636024. Target conditions include Safety, Pharmacokinetics, Pharmacodynamics of AZD7594.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01636024 | Phase 1 | Completed |
Competing Products
20 competing products in Safety